Bayer (BAYRY) said the U.S. Supreme Court today announced that it will review the Durnell Roundup case. “Monsanto petitioned the court to hear Durnell in April 2025 and address the split in authority among federal circuit courts on the application of federal preemption, a cross-cutting issue in the Roundup litigation. The company expects a decision on the merits during the Court’s 2026 session, which ends in June,” Bayer said in a statement. The company ‘welcomes” the Supreme Court decision to review the Durnell case.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- U.S. Supreme Court to hear Bayer’s appeal of Roundup lawsuits, Bloomberg says
- Bayer to acquire AT-01 and AT-05 from Attralus, terms undisclosed
- Bayer’s New Phase 4 ATTR-CM Study Tests Switching From Tafamidis to Acoramidis
- Bayer’s FINE-REAL Korea Study Tracks Real-World Use of Finerenone in Diabetic Kidney Disease
- Bayer’s New Parkinson’s Study Builds a Long-Term Data Edge, Not Near-Term Profits